论文信息 - 2023 ESC Guidelines for the management of cardiomyopathies.

[85] M. Laredo,et al. Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[86] C. Israel,et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. , 2021, European heart journal.

[87] I. V. Van Gelder,et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. , 2021, European heart journal.

[88] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[89] F. Sacher,et al. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[90] B. Gelb,et al. Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association , 2021, Circulation. Genomic and precision medicine.

[91] C. Autore,et al. Yield of bone scintigraphy screening for transthyretin‐related cardiac amyloidosis in different conditions: Methodological issues and clinical implications , 2021, European journal of clinical investigation.

[92] Shuiyun Wang,et al. Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy , 2021, Frontiers in Cardiovascular Medicine.

[93] J. Dunst,et al. Recommendations regarding cardiac stereotactic body radiotherapy for treatment-refractory ventricular tachycardia. , 2021, Heart rhythm.

[94] G. Breithardt,et al. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure , 2021, Circulation.

[95] E. Fernlund,et al. Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk‐score and HCMRisk‐Kids score , 2021, Acta paediatrica.

[96] Liang Chen,et al. Early outcomes of septal myectomy for obstructive hypertrophic cardiomyopathy in children with Noonan syndrome. , 2021, Seminars in thoracic and cardiovascular surgery.

[97] R. Weintraub,et al. Overview of Cardiomyopathies in Childhood , 2021, Frontiers in Pediatrics.

[98] D. Kokkinidis,et al. Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis. , 2021, International Journal of Cardiology.

[99] R. Płoski,et al. A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk). , 2021, International journal of cardiology.

[100] J. Towbin,et al. Diagnosis and Management of Myocarditis in Children , 2021, Circulation.

[101] M. Holtgrewe,et al. Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis , 2021, Circulation. Genomic and precision medicine.

[102] N. Geller,et al. Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR. , 2021, JACC. Clinical electrophysiology.

[103] Amit R. Patel,et al. Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy. , 2021, European Heart Journal-Cardiovascular Imaging.

[104] H. Watkins. Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy , 2021, Circulation.

[105] M. Mirsaeidi,et al. COVID-19 and Cardiomyopathy: A Systematic Review , 2021, Frontiers in Cardiovascular Medicine.

[106] Christopher A. Miller,et al. Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy. , 2021, Journal of the American College of Cardiology.

[107] I. Olivotto,et al. Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration. , 2021, International Journal of Cardiology.

[108] G. Lip,et al. The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[109] A. Zwinderman,et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction , 2021, European heart journal.

[110] James A. White,et al. 2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society. , 2021, The Canadian journal of cardiology.

[111] A. Kimura,et al. Histopathological changes of myocytes in restrictive cardiomyopathy , 2021, Medical Molecular Morphology.

[112] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[113] W. Chung,et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[114] S. Yusuf,et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. , 2021, The New England journal of medicine.

[115] J. Spertus,et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial , 2021, The Lancet.

[116] P. Elliott,et al. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure. , 2021, JAMA cardiology.

[117] L. Mestroni,et al. Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy. , 2021, International journal of cardiology.

[118] Nikolaos S. Papageorgiou,et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[119] K. McGeechan,et al. A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator in patients with genetic heart diseases , 2021, medRxiv.

[120] H. Calkins,et al. Clinical Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Insights from the Johns Hopkins ARVC Program. , 2021, Heart rhythm.

[121] R. Kornowski,et al. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy , 2021, European journal of heart failure.

[122] Lisa J. Martin,et al. Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study , 2021, Journal of the American Heart Association.

[123] Corrigendum to: Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. , 2021, European Heart Journal.

[124] J. Towbin,et al. Myopathic Cardiac Genotypes Increase Risk for Myocarditis , 2021, JACC. Basic to translational science.

[125] J. Seidman,et al. Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy , 2021, Circulation.

[126] D. Judge,et al. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework , 2021, Circulation. Genomic and precision medicine.

[127] V. Christoffels,et al. Lack of morphometric evidence for ventricular compaction in humans. , 2021, Journal of cardiology.

[128] U. Eriksson,et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. , 2021, European heart journal.

[129] T. Kubo,et al. Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy , 2021, Circulation reports.

[130] I. Olivotto,et al. Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy. , 2021, Heart failure clinics.

[131] D. De Wolf,et al. Needs and experiences of adolescents with congenital heart disease and parents in the transitional process: A qualitative study. , 2021, Journal of pediatric nursing.

[132] E. Ashley,et al. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy , 2021, European heart journal.

[133] D. Packer,et al. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation , 2021, Europace.

[134] J. Blay,et al. European Reference Networks: challenges and opportunities , 2021, Journal of Community Genetics.

[135] M. Laredo,et al. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy. , 2021, Canadian Journal of Cardiology.

[136] G. Limongelli,et al. Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes , 2021, Frontiers in Pediatrics.

[137] E. Arbustini,et al. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. , 2021, Journal of the American College of Cardiology.

[138] P. Ponikowski,et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure , 2021, European journal of heart failure.

[139] D. Mark,et al. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure , 2021, Circulation.

[140] A. Bogers,et al. Predicting outcome in children with dilated cardiomyopathy: the use of repeated measurements of risk factors for outcome , 2021, ESC heart failure.

[141] J. Brugada,et al. Malignant Arrhythmogenic Role Associated with RBM20: A Comprehensive Interpretation Focused on a Personalized Approach , 2021, Journal of personalized medicine.

[142] Y. Chien,et al. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients , 2021, Molecular Genetics and Metabolism.

[143] A. Cohen-Solal,et al. The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. , 2021, JACC. Heart failure.

[144] M. Farrall,et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity , 2021, Nature Genetics.

[145] Eric Y. Yang,et al. The Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients with Non-Ischemic Cardiomyopathy. , 2021, Circulation.

[146] H. Reichenspurner,et al. Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome , 2021, Journal of the American Heart Association.

[147] J. Gornbein,et al. Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation , 2021, Journal of the American Heart Association.

[148] M. Haissaguerre,et al. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long‐term results and clinical outcomes , 2021, Journal of cardiovascular electrophysiology.

[149] G. Lip,et al. Integrated care and outcomes in patients with atrial fibrillation and comorbidities , 2021, European journal of clinical investigation.

[150] M. Khan,et al. Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy. , 2021, JACC. Cardiovascular interventions.

[151] E. Lyseggen,et al. Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[152] Marc S. Williams,et al. A dyadic approach to the delineation of diagnostic entities in clinical genomics. , 2021, American journal of human genetics.

[153] H. Seggewiss,et al. Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition? , 2020, International journal of cardiology.

[154] A. Camm,et al. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. , 2020, JAMA.

[155] F. Violi,et al. The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study. , 2020, European journal of internal medicine.

[156] D. Judge,et al. An Evidence-based Assessment of Genes in Dilated Cardiomyopathy , 2020, medRxiv.

[157] B. Giorgi,et al. ‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[158] Frederick T. Han,et al. Meta-Analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction. , 2020, The American journal of cardiology.

[159] E. Ashley,et al. Associations Between Female Sex, Sarcomere Variants and Clinical Outcomes in Hypertrophic Cardiomyopathy. , 2020, Circulation. Genomic and precision medicine.

[160] Feng Hu,et al. Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis , 2020, Journal of geriatric cardiology : JGC.

[161] F. Ruschitzka,et al. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria. , 2020, Circulation. Genomic and precision medicine.

[162] Stefan L. Zimmerman,et al. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation. Arrhythmia and electrophysiology.

[163] Lian‐Yu Lin,et al. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study , 2020, Aging.

[164] E. Rosenthal,et al. Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[165] Matthew W. Martinez,et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.

[166] P. Elliott,et al. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect , 2020, Nature Genetics.

[167] M. Shao,et al. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. , 2020, The New England journal of medicine.

[168] C. Morillo,et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. , 2020, The New England journal of medicine.

[169] D. Andreini,et al. Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy , 2020, Circulation. Arrhythmia and electrophysiology.

[170] S. Colan,et al. Pediatric Heart Network Echocardiographic Z Scores: Comparison with Other Published Models. , 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[171] Daniel P. Morin,et al. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis. , 2020, Progress in cardiovascular diseases.

[172] T. Seidler,et al. Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM CMR Substudy Analysis. , 2020, Circulation.

[173] J. Mogensen,et al. Clinical Profile of Cardiac Involvement in Danon Disease , 2020, Circulation. Genomic and precision medicine.

[174] N. Smedira,et al. Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach , 2020, Journal of cardiac surgery.

[175] A. Pereira,et al. Phenotype–genotype analysis of 242 individuals with RASopathies: 18‐year experience of a tertiary center in Brazil , 2020, American journal of medical genetics. Part C, Seminars in medical genetics.

[176] P. Kellman,et al. Reduction in CMR Derived Extracellular Volume with Patisiran Indicates Cardiac Amyloid Regression. , 2020, JACC. Cardiovascular imaging.

[177] H. Bundgaard,et al. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences , 2020, Journal of Medical Genetics.

[178] G. Sinagra,et al. Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine , 2020, Journal of clinical medicine.

[179] M. Morshuis,et al. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry. , 2020, European heart journal.

[180] V. Fuster,et al. Association Between Left Ventricular Noncompaction and Vigorous Physical Activity. , 2020, Journal of the American College of Cardiology.

[181] G. Lip,et al. Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort , 2020, European Journal of Internal Medicine.

[182] C. Morillo,et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families , 2020, Heart rhythm.

[183] L. Tavazzi,et al. Prospective follow-up in various subtypes of cardiomyopathies: Insights from the ESC EORP Cardiomyopathy Registry. , 2020, European heart journal. Quality of care & clinical outcomes.

[184] J. Politei,et al. Incidental finding of cornea verticillata or lamellar inclusions in kidney biopsy: measurement of lyso-Gb3 in plasma defines between Fabry disease and drug-induced phospholipidosis. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[185] R. Siegel,et al. Anticoagulation for Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review. , 2020, Heart rhythm.

[186] G. Boriani,et al. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[187] K. Kosaki,et al. Peripheral pulmonary stenosis with Noonan syndrome treated by balloon pulmonary angioplasty , 2020, Pulmonary circulation.

[188] J. Mogensen,et al. Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives , 2020, Circulation. Heart failure.

[189] D. Fatkin,et al. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene , 2020, Circulation. Heart failure.

[190] S. Ommen,et al. Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better , 2020, British Journal of Sports Medicine.

[191] G. Aquaro,et al. Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy , 2020, ESC heart failure.

[192] M. Henein,et al. Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis , 2020, Journal of clinical medicine.

[193] R. Manka,et al. Differentiating Hereditary Arrhythmogenic Right Ventricular Cardiomyopathy from Cardiac Sarcoidosis Fulfilling 2010 ARVC Task Force Criteria. , 2020, Heart rhythm.

[194] Y. Pinto,et al. Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology , 2020, ESC heart failure.

[195] L. Yeates,et al. "Concealed cardiomyopathy" as a cause of previously unexplained sudden cardiac arrest. , 2020, International journal of cardiology.

[196] R. Doukky,et al. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls , 2020, Journal of Nuclear Cardiology.

[197] D. Judge,et al. Epidemiology of the inherited cardiomyopathies , 2020, Nature Reviews Cardiology.

[198] S. Heymans,et al. Implications of Genetic Testing in Dilated Cardiomyopathy , 2020, Circulation. Genomic and precision medicine.

[199] Michel G Khouri,et al. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis. , 2020, JACC. Clinical electrophysiology.

[200] M. Maurer,et al. Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis , 2020, JACC. CardioOncology.

[201] M. Schalij,et al. Prevalence and Prognostic Impact of Pathogenic Variants in Patients With Dilated Cardiomyopathy Referred for Ventricular Tachycardia Ablation. , 2020, JACC. Clinical electrophysiology.

[202] J. Curtis,et al. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy , 2020, Journal of the American Heart Association.

[203] G. Breithardt,et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[204] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[205] G. T. Gunnarsson,et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. , 2020, European heart journal.

[206] S. Solomon,et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial , 2020, The Lancet.

[207] J. Seidman,et al. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in TNNI3 and TNNT2 That Are Common in Chinese Patients , 2020, Circulation. Genomic and precision medicine.

[208] Angelo B. Biviano,et al. Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding , 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[209] K. Vigen,et al. Recommendations for Imaging Patients With Cardiac Implantable Electronic Devices (CIEDs) , 2020, Journal of magnetic resonance imaging : JMRI.

[210] H. Rakowski,et al. Primary Prevention Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy - Are There Predictors of Appropriate Therapy? , 2020, Heart rhythm.

[211] F. Crea,et al. Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology , 2020, Current Cardiology Reports.

[212] P. Lambiase,et al. Subcutaneous or Transvenous Defibrillator Therapy , 2020, New England Journal of Medicine.

[213] P. Elliott,et al. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers , 2020, Journal of the American College of Cardiology.

[214] Shu Zhang,et al. Pulmonary vein isolation implemented by second-generation cryoballoon for treating hypertrophic cardiomyopathy patients with symptomatic atrial fibrillation: a case-control study , 2020, Journal of geriatric cardiology : JGC.

[215] Adhi Arya,et al. Angiotensin Receptor and Neprylisin Inhibitor: A new drug in pediatric cardiologist's armamentarium , 2020, Annals of Pediatric Cardiology.

[216] M. Śpiewak,et al. LGE for Risk Stratification in Primary Prevention in Children With HCM. , 2020, JACC. Cardiovascular imaging.

[217] J. Estep,et al. Digoxin Use in Cardiac Amyloidosis. , 2020, The American journal of cardiology.

[218] J. Svendsen,et al. Pregnancies, ventricular arrhythmias, and substrate progression in women with arrhythmogenic right ventricular cardiomyopathy in the Nordic ARVC Registry. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[219] D. Andreini,et al. Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies , 2020, Circulation.

[220] I. Olivotto,et al. The Importance of Sex Differences in Patients with Hypertrophic Cardiomyopathy - Tailoring Management and Future Perspectives. , 2020, American Journal of the Medical Sciences.

[221] Sanjiv J. Shah,et al. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. , 2020, JACC. Heart failure.

[222] L. Yeates,et al. Needs analysis of parents following sudden cardiac death in the young , 2020, Open Heart.

[223] Angharad M Roberts,et al. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis. , 2020, Journal of the American College of Cardiology.

[224] P. Elliott,et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease , 2020, European journal of heart failure.

[225] I. Porto,et al. Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: lessons from the coronavirus disease 2019 lockdown in Italy , 2020, Journal of cardiovascular medicine.

[226] E. Heist,et al. Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy , 2020, Journal of the American Heart Association.

[227] B. Maron,et al. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. , 2020, Journal of the American College of Cardiology.

[228] A. Mazzanti,et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.

[229] Jason T. Su,et al. MRI in pediatric and congenital heart disease patients with CIEDs and epicardial or abandoned leads , 2020, Pacing and clinical electrophysiology : PACE.

[230] C. Autore,et al. Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study , 2020, British Journal of Sports Medicine.

[231] W. Stevenson,et al. Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[232] B. Joung,et al. Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study , 2020, Journal of arrhythmia.

[233] J. Svendsen,et al. Absence of ECG task force criteria does not rule out structural changes in genotype positive ARVC patients. , 2020, International journal of cardiology.

[234] M. Digilio,et al. Atypical cardiac defects in patients with RASopathies: Updated data on CARNET study , 2020, Birth defects research.

[235] A. Natale,et al. Endo‐epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta‐analysis , 2020, Journal of cardiovascular electrophysiology.

[236] G. Aquaro,et al. EP News: Clinical , 2020, Heart Rhythm.

[237] B. Davis,et al. Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic Criteria. , 2020, Texas Heart Institute journal.

[238] G. Lip,et al. The Effect of Integrated Care Management on Dementia in Atrial Fibrillation , 2020, Journal of clinical medicine.

[239] W. Stevenson,et al. Electroanatomical Voltage Mapping to Distinguish Right-Sided Cardiac Sarcoidosis From Arrhythmogenic Right Ventricular Cardiomyopathy. , 2020, JACC. Clinical electrophysiology.

[240] M. Emdin,et al. Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis. , 2020, European journal of internal medicine.

[241] L. Fauchier,et al. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices. , 2020, Archives of cardiovascular diseases.

[242] R. Barriales-Villa,et al. Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA , 2020, Revista Española de Cardiología.

[243] S. Colan,et al. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy , 2020, Circulation.

[244] K. Klingel,et al. Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene , 2020, Journal of the American Heart Association.

[245] A. Philippakis,et al. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy , 2020, Nature Communications.

[246] G. Lip,et al. Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial , 2020, Journal of the American Heart Association.

[247] S. Priori,et al. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation.

[248] É. Marijon,et al. Psychological Support and Medical Screening of First-Degree Relatives of Sudden Cardiac Arrest Victims. , 2020, JACC. Clinical electrophysiology.

[249] S. Tezenas du Montcel,et al. Psychosocial Impact of Predictive Genetic Testing in Hereditary Heart Diseases: The PREDICT Study , 2020, Journal of clinical medicine.

[250] G. Lip,et al. Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry , 2020, Journal of clinical medicine.

[251] F. Domínguez,et al. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center. , 2020, Revista espanola de cardiologia.

[252] Stefan L. Zimmerman,et al. Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[253] C. Basso,et al. Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis. , 2020, JACC. Cardiovascular imaging.

[254] G. Lip,et al. Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[255] Michael A. Burke,et al. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers , 2020, Open Heart.

[256] James A. White,et al. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy , 2020, Circulation. Cardiovascular imaging.

[257] Yingying Tang,et al. Lessons learned from testing cardiac channelopathy and cardiomyopathy genes in individuals who died suddenly: A two‐year prospective study in a large medical examiner’s office with an in‐house molecular genetics laboratory and genetic counseling services , 2020, Journal of genetic counseling.

[258] E. Ashley,et al. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction , 2020, Circulation.

[259] D. Corrado,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy , 2020, Journal of the American Heart Association.

[260] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[261] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[262] B. Gelb,et al. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment , 2020, American journal of medical genetics. Part C, Seminars in medical genetics.

[263] D. Andreini,et al. CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. , 2020, JACC. Cardiovascular imaging.

[264] P. Elliott,et al. Biventricular pacemaker therapy improves exercise capacity in patients with non‐obstructive hypertrophic cardiomyopathy via augmented diastolic filling on exercise , 2020, European journal of heart failure.

[265] S. Goland,et al. Peripartum Cardiomyopathy: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.

[266] T. Edvardsen,et al. Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype , 2020, Journal of the American Heart Association.

[267] J. Cleveland,et al. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent , 2020, JAMA cardiology.

[268] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[269] X. Qiu,et al. Five‐year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy , 2020, Journal of cardiovascular electrophysiology.

[270] O. Alfieri,et al. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team. , 2020, International journal of cardiology.

[271] D. Stub,et al. Alcohol Abstinence in Drinkers with Atrial Fibrillation. , 2020, The New England journal of medicine.

[272] P. Charron,et al. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy , 2020, Open medicine.

[273] Timothy M. Markman,et al. Characterization of Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy With Recurrent Ventricular Tachycardia After Ablation , 2020, Circulation: Arrhythmia and Electrophysiology.

[274] E. Ashley,et al. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy. , 2020, JAMA cardiology.

[275] G. Pontone,et al. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. , 2020, JACC. Cardiovascular imaging.

[276] Paul L. Hess,et al. Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). , 2019, American Journal of Cardiology.

[277] Andreas Hauptmann,et al. Rapid whole-heart CMR with single volume super-resolution , 2019, Journal of Cardiovascular Magnetic Resonance.

[278] Amit R. Patel,et al. Cardiac Magnetic Resonance in Patients With Cardiac Implantable Electronic Devices , 2019, Journal of thoracic imaging.

[279] S. Ommen,et al. Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy. , 2019, American heart journal.

[280] G. Pontone,et al. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. , 2019, JACC. Cardiovascular imaging.

[281] J. Seidman,et al. Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[282] J. Svendsen,et al. Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry). , 2019, American Journal of Cardiology.

[283] W. Saliba,et al. No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis. , 2019, JACC. Clinical electrophysiology.

[284] J. Moon,et al. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy , 2019, Circulation. Cardiovascular imaging.

[285] Alexandra M. Sanchez,et al. Thromboembolic Outcomes of Different Anticoagulation Strategies for Patients with Atrial Fibrillation in the Setting of Hypertrophic Cardiomyopathy: A Systematic Review. , 2019, Journal of atrial fibrillation.

[286] P. Elliott,et al. Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population. , 2019, JAMA cardiology.

[287] G. Hindricks,et al. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial. , 2019, Circulation: Arrhythmia and Electrophysiology.

[288] D. De Wolf,et al. Development of a transition program for adolescents with congenital heart disease , 2019, European Journal of Pediatrics.

[289] Jagmeet P. Singh,et al. Utility of Computed Tomography to Predict Ventricular Arrhythmias in Patients With Nonischemic Cardiomyopathy Receiving Cardiac Resynchronization Therapy. , 2019, American Journal of Cardiology.

[290] Feng Hu,et al. Effect of Pregnancy in Arrhythmogenic Right Ventricular Cardiomyopathy. , 2019, American Journal of Cardiology.

[291] Sang Min Park,et al. Changes in exercise frequency and cardiovascular outcomes in older adults. , 2019, European Heart Journal.

[292] M. Link,et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. , 2019, Heart rhythm.

[293] N. Geller,et al. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. , 2019, Journal of the American College of Cardiology.

[294] G. Lip,et al. Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients , 2019, Journal of the American Heart Association.

[295] B. Maron,et al. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy , 2019, Journal of the American Heart Association.

[296] Douglas Y Mah,et al. Successful bilateral thoracoscopic sympathectomy for recurrent ventricular arrhythmia in a pediatric patient with hypertrophic cardiomyopathy , 2019, HeartRhythm case reports.

[297] M. Link,et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis , 2019, European heart journal.

[298] B. Maron,et al. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. , 2019, The American journal of cardiology.

[299] B. Meiser,et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[300] Y. Pinto,et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. , 2019, European heart journal cardiovascular Imaging.

[301] N. Sreeram,et al. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. , 2019, Heart rhythm.

[302] J. Ingles. Psychological Issues in Managing Families with Inherited Cardiovascular Diseases. , 2019, Cold Spring Harbor perspectives in medicine.

[303] K. Klingel,et al. Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy. , 2019, Cardiovascular diagnosis and therapy.

[304] L. Mestroni,et al. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. , 2019, Journal of the American College of Cardiology.

[305] R. Weintraub,et al. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids). , 2019, JAMA cardiology.

[306] T. Edvardsen,et al. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy , 2019, European heart journal.

[307] A. Lin,et al. Cardiac transplantation in children with Noonan syndrome , 2019, Pediatric transplantation.

[308] H. Schaff,et al. Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome. , 2019, Seminars in Thoracic and Cardiovascular Surgery.

[309] J. Brugada,et al. Influence of risk factors in the ESC‐EHRA EORP atrial fibrillation ablation long‐term registry , 2019, Pacing and clinical electrophysiology : PACE.

[310] H. Bundgaard,et al. Alcohol septal ablation in patients with severe septal hypertrophy , 2019, Heart.

[311] R. Rajani,et al. Emerging role of cardiac computed tomography in heart failure , 2019, ESC Heart Failure.

[312] Yong-Jin Kim,et al. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians , 2019, Heart.

[313] G. Hindricks,et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[314] P. Lambiase,et al. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report , 2019, European journal of heart failure.

[315] Dudley J Pennell,et al. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement , 2019, JACC. Cardiovascular imaging.

[316] T. Kubo,et al. Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort　- Results From Kochi RYOMA Study. , 2019, Circulation Journal.

[317] Yong-Jin Kim,et al. Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation. , 2019, Stroke.

[318] G. Marcus,et al. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment , 2019, Journal of cardiovascular electrophysiology.

[319] R. Porcher,et al. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. , 2019, Circulation.

[320] C. Perret,et al. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype‐phenotype correlations , 2019, Clinical genetics.

[321] G. Lip,et al. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study , 2019, Thrombosis and Haemostasis.

[322] S. Colan,et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[323] C. Autore,et al. Sex-related differences in cardiomyopathies. , 2019, International journal of cardiology.

[324] K. Mandal,et al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. , 2019, Heart Rhythm.

[325] Vassilios J. Bezzerides,et al. Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. , 2019, Journal of the American College of Cardiology.

[326] A. Farcomeni,et al. ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. , 2019, The American journal of medicine.

[327] F. Violi,et al. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. , 2019, Mayo Clinic proceedings.

[328] P. Ponikowski,et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy , 2019, European journal of heart failure.

[329] S. G. Temel,et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death , 2019, European Journal of Human Genetics.

[330] P. James,et al. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy , 2019, Genetics in Medicine.

[331] D. Schwartz,et al. Costello syndrome: Clinical phenotype, genotype, and management guidelines , 2019, American journal of medical genetics. Part A.

[332] J. Veselka,et al. Head-Up Tilt Test in Risk Stratification of Patients with Hypertrophic Cardiomyopathy , 2019, International Journal of Angiology.

[333] E. Ashley,et al. Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging , 2019, PloS one.

[334] D. Lacombe,et al. Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients , 2019, Clinical Genetics.

[335] G. Filippatos,et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations , 2019, European journal of heart failure.

[336] H. Bundgaard,et al. Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis. , 2019, European heart journal.

[337] S. Ware,et al. The impact of cardiovascular genetic counseling on patient empowerment , 2019, Journal of Genetic Counseling.

[338] R. Omar,et al. A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[339] K. Hayashi,et al. Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation. , 2019, Heart rhythm.

[340] L. Schöls,et al. Patient‐reported outcomes in Friedreich’s ataxia after withdrawal from idebenone , 2019, Acta neurologica Scandinavica.

[341] J. Deharo,et al. High risk of heart failure associated with desmoglein‐2 mutations compared to plakophilin‐2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia , 2019, European journal of heart failure.

[342] M. Ashworth,et al. Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy. , 2019, International Journal of Cardiology.

[343] N. Smedira,et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. , 2019, The Journal of thoracic and cardiovascular surgery.

[344] Matthew W. Martinez,et al. Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association. , 2019, Circulation. Genomic and precision medicine.

[345] P. Kellman,et al. Native T1 and Extracellular Volume in Transthyretin Amyloidosis. , 2019, JACC. Cardiovascular imaging.

[346] G. Filippatos,et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.

[347] Parth N. Patel,et al. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy , 2019, Circulation.

[348] G. Hindricks,et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[349] K. Anstrom,et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[350] R. Hofstra,et al. Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy. , 2019, Journal of the American College of Cardiology.

[351] Michael Fu,et al. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[352] J. Svendsen,et al. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. , 2019, American Journal of Cardiology.

[353] B. Maron,et al. Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)". , 2019, Circulation.

[354] M. Walsh,et al. A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.

[355] G. Parati,et al. Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy. , 2019, Clinical Journal of Sports Medicine.

[356] J. Mogensen,et al. Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy , 2019, Circulation: Heart Failure.

[357] S. Ommen,et al. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy , 2019, JAMA cardiology.

[358] K. Kuck,et al. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach , 2019, Journal of the American Heart Association.

[359] R. de Silva,et al. Guidelines on the diagnosis and management of the progressive ataxias , 2019, Orphanet Journal of Rare Diseases.

[360] R. Boubertakh,et al. MRI for patients with cardiac implantable electronic devices: simplifying complexity with a ‘one-stop’ service model , 2019, BMJ Quality & Safety.

[361] Jian Wang,et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort , 2019, Orphanet Journal of Rare Diseases.

[362] C. Caleshu,et al. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes , 2019, Circulation. Genomic and precision medicine.

[363] Roger D. White,et al. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis. , 2019, Journal of the American College of Cardiology.

[364] S. Saba,et al. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis. , 2019, JACC. Clinical electrophysiology.

[365] Brian Lilleness,et al. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. , 2019, Blood.

[366] G. Lip,et al. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study , 2019, Thrombosis and Haemostasis.

[367] D. Pennell,et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial , 2019, The Lancet.

[368] J. Cnota,et al. Prevalence of Noonan spectrum disorders in a pediatric population with valvar pulmonary stenosis , 2018, Congenital heart disease.

[369] C. Caleshu,et al. Evolving Decisions: Perspectives of Active and Athletic Individuals with Inherited Heart Disease Who Exercise Against Recommendations , 2018, Journal of Genetic Counseling.

[370] J. Kaski,et al. Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom , 2018, European heart journal.

[371] R. Hauer,et al. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete's Heart. , 2018, JACC. Clinical electrophysiology.

[372] Seil Oh,et al. Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study. , 2018, International journal of cardiology.

[373] H. Seggewiss,et al. Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy. , 2018, Journal of the American College of Cardiology.

[374] M. Yacoub,et al. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy. , 2018, International journal of cardiology.

[375] J. Skinner,et al. Predictors of β-blocker adherence in cardiac inherited disease , 2018, Open Heart.

[376] S. Chevret,et al. CONGENITAL : CARDIOMYOPATHY Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy G , 2022 .

[377] G. Lip,et al. Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study , 2018, Chest.

[378] J. Kaski,et al. Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy , 2018, Archives of Disease in Childhood.

[379] R. Płoski,et al. Autosomal recessive transmission of familial nonsyndromic dilated cardiomyopathy due to compound desmoplakin gene mutations. , 2018, Polish Archives of Internal Medicine.

[380] P. Elliott,et al. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations. , 2018, Journal of the American College of Cardiology.

[381] G. Lip,et al. Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy. , 2018, Journal of the American College of Cardiology.

[382] G. Lip,et al. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. , 2018, American Journal of Medicine.

[383] N. Boddaert,et al. Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy: A paediatric case series. , 2018, International Journal of Cardiology.

[384] D. Cannom,et al. Highlights From the Circulation Family of Journals , 2018, Circulation. Arrhythmia and electrophysiology.

[385] P. Elliott,et al. Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation. , 2018, International journal of cardiology.

[386] Y. Adler,et al. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy. , 2018, European Heart Journal.

[387] Stefan Neubauer,et al. Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications , 2018, European heart journal cardiovascular Imaging.

[388] H. Lee,et al. Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI , 2018, Scientific Reports.

[389] G. Filippatos,et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry , 2018, European heart journal.

[390] R. Baranowski,et al. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy , 2018, Clinical cardiology.

[391] E. Ashley,et al. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy , 2018, Circulation.

[392] Thor Edvardsen,et al. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study. , 2018, JACC. Cardiovascular imaging.

[393] D. Corrado,et al. Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete's Heart by Using Imaging. , 2018, JACC. Cardiovascular imaging.

[394] H. Bundgaard,et al. Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[395] Sanjiv J. Shah,et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy , 2018, The New England journal of medicine.

[396] M. Brignole,et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS , 2018, European heart journal.

[397] Susanna Price,et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.

[398] Amit R. Patel,et al. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy , 2018, Circulation.

[399] H. Crijns,et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial , 2018, European heart journal.

[400] D. Ramsdale,et al. Outcomes of Cardiac Screening in Adolescent Soccer Players , 2018, The New England journal of medicine.

[401] A. Petrie,et al. A new staging system for cardiac transthyretin amyloidosis , 2018, European heart journal.

[402] P. Charron,et al. External validation of risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers , 2019, European journal of heart failure.

[403] Akshay S. Desai,et al. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial. , 2018, JACC. Heart failure.

[404] A. Holtermann,et al. Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up. , 2018, Journal of the American College of Cardiology.

[405] N. Smedira,et al. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. , 2018, Journal of the American College of Cardiology.

[406] J. Atallah,et al. When to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy. , 2018, Circulation. Genomic and precision medicine.

[407] Megan E. Grove,et al. Clinical Cardiovascular Genetic Counselors Take a Leading Role in Team-based Variant Classification , 2018, Journal of Genetic Counseling.

[408] F. Marchlinski,et al. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials , 2018, Journal of Interventional Cardiac Electrophysiology.

[409] C. Steinwender,et al. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers , 2018, Journal of Cardiovascular Magnetic Resonance.

[410] A. Barnes,et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis , 2018, European heart journal cardiovascular Imaging.

[411] G. Hindricks,et al. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[412] R. Hauer,et al. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis. , 2018, Heart rhythm.

[413] G. Lip,et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[414] S. Prabhu,et al. Regression of Diffuse Ventricular Fibrosis Following Restoration of Sinus Rhythm With Catheter Ablation in Patients With Atrial Fibrillation and Systolic Dysfunction: A Substudy of the CAMERA MRI Trial. , 2018, JACC. Clinical electrophysiology.

[415] R. Bai,et al. Long‐term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy , 2018, Journal of cardiovascular electrophysiology.

[416] Michael E. Hall,et al. Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study , 2018, Circulation.

[417] D. Pennell,et al. Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy , 2018, European journal of heart failure.

[418] Christophe Leclercq,et al. 2018 ESC Guidelines for the diagnosis and management of syncope , 2018, European heart journal.

[419] D. O’Regan,et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.

[420] L. Tavazzi,et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies , 2018, European heart journal.

[421] M. Ackerman,et al. Idiopathic Restrictive Cardiomyopathy in Children and Young Adults. , 2018, The American journal of cardiology.

[422] P. Charron,et al. Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2018, International journal of cardiology.

[423] A. Oron,et al. Comparison of Transplant Waitlist Outcomes for Pediatric Candidates Supported by Ventricular Assist Devices Versus Medical Therapy , 2018, Pediatric Critical Care Medicine.

[424] Kristen L. Kucera,et al. Etiology of Sudden Cardiac Arrest and Death in US Competitive Athletes: A 2-Year Prospective Surveillance Study. , 2018, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[425] T. Edvardsen,et al. Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy , 2018, European heart journal cardiovascular Imaging.

[426] C. Eng,et al. Fabry disease revisited: Management and treatment recommendations for adult patients. , 2018, Molecular genetics and metabolism.

[427] M. Digilio,et al. Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies. , 2018, Heart failure clinics.

[428] G. Boriani,et al. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators , 2018, Circulation. Arrhythmia and electrophysiology.

[429] R. Oldenburg,et al. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy , 2018, Circulation. Genomic and precision medicine.

[430] T. Edvardsen,et al. Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy. , 2018, JACC. Clinical electrophysiology.

[431] D. Stockton,et al. Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study , 2018, Genetics in Medicine.

[432] J. Minnier,et al. Standardized Goal‐Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[433] J. Markley,et al. Interactions of iron-bound frataxin with ISCU and ferredoxin on the cysteine desulfurase complex leading to Fe-S cluster assembly , 2018, Journal of inorganic biochemistry.

[434] D. Dingli,et al. Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use? , 2018, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[435] James W Long,et al. Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[436] C. Ravishankar,et al. Disopyramide use in infants and children with hypertrophic cardiomyopathy , 2018, Cardiology in the Young.

[437] S. Ommen,et al. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[438] R. Lange,et al. Clinical long-term outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in infants , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[439] H. Calkins,et al. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2018, Circulation: Arrhythmia and Electrophysiology.

[440] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[441] I. Olivotto,et al. Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria. , 2018, Journal of the American College of Cardiology.

[442] R. Srinivasan,et al. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995–2017 , 2018, Journal of Medical Genetics.

[443] S. Qureshi,et al. Results of balloon pulmonary valvoplasty in children with Noonan’s syndrome , 2018, Cardiology in the Young.

[444] Birgit Funke,et al. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel , 2018, Genetics in Medicine.

[445] M. Friedberg,et al. Association of Echocardiographic Parameters of Right Ventricular Remodeling and Myocardial Performance With Modified Task Force Criteria in Adolescents With Arrhythmogenic Right Ventricular Cardiomyopathy , 2019, Circulation. Cardiovascular imaging.

[446] Stefan L. Zimmerman,et al. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices , 2017, The New England journal of medicine.

[447] M. Link,et al. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy , 2017, Circulation.

[448] Karen S. Frese,et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy , 2017, European heart journal.

[449] A. Petrie,et al. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid , 2017, European heart journal cardiovascular Imaging.

[450] H. Calkins,et al. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex. , 2017, International journal of cardiology.

[451] A. Keren,et al. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) , 2017, Circulation.

[452] J. Ingles,et al. Communication of genetic information to families with inherited rhythm disorders. , 2017, Heart rhythm.

[453] H. Calkins,et al. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy , 2017, Circulation.

[454] A. Brandes,et al. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure , 2017, Circulation.

[455] B. Jiang,et al. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy , 2017, Heart & lung : the journal of critical care.

[456] T. Edvardsen,et al. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation , 2017, European heart journal.

[457] William J. Bryant,et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.

[458] A. Mahajan,et al. Thoracic Epidural Anesthesia Can Be Effective for the Short‐Term Management of Ventricular Tachycardia Storm , 2017, Journal of the American Heart Association.

[459] S. Prabhu,et al. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. , 2017, Journal of the American College of Cardiology.

[460] M. Digilio,et al. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. , 2017, International journal of cardiology.

[461] Richard B. Thompson,et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[462] M. Leon,et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement , 2017, European heart journal.

[463] J. McMurray,et al. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis , 2017, Heart.

[464] E. Fernlund,et al. Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score , 2017, Open Heart.

[465] S. Plein,et al. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography , 2017, European heart journal cardiovascular Imaging.

[466] D. Judge,et al. Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis , 2017, Cardiovascular research.

[467] E. Ashley,et al. Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation , 2017, Circulation. Cardiovascular genetics.

[468] V. Dilsizian,et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology , 2017, European heart journal cardiovascular Imaging.

[469] G. Lip. The ABC pathway: an integrated approach to improve AF management , 2017, Nature Reviews Cardiology.

[470] B. Maron,et al. Classification, Epidemiology, and Global Burden of Cardiomyopathies. , 2017, Circulation research.

[471] M. Gertz,et al. Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. , 2017, Circulation research.

[472] M. Sheppard,et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology , 2017, Virchows Archiv.

[473] C. Tseng,et al. Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review. , 2017, JACC Clinical Electrophysiology.

[474] P. Ponikowski,et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) , 2017, European journal of heart failure.

[475] G. Guyatt,et al. Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis , 2017, Heart.

[476] G. Limongelli,et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. , 2017, Pediatrics and neonatology.

[477] K. Sliwa,et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study , 2017, European heart journal.

[478] M. Sabater-Molina,et al. Factors Influencing the Phenotypic Expression of Hypertrophic Cardiomyopathy in Genetic Carriers. , 2017, Revista espanola de cardiologia.

[479] Johannes M. I. H. Gho,et al. Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. , 2017, Heart rhythm.

[480] S. Dorbala,et al. Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies , 2017, Heart Failure Reviews.

[481] A. M. Leone,et al. A current approach to heart failure in Duchenne muscular dystrophy , 2017, Heart.

[482] Marmar Vaseghi,et al. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. , 2017, Journal of the American College of Cardiology.

[483] B. Yashar,et al. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup , 2017, Genetics in Medicine.

[484] A. Rigby,et al. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. , 2017, Journal of the American College of Cardiology.

[485] K. Ball,et al. Impact of the implantable cardioverter defibrillator on confidence to undertake physical activity in inherited heart disease: A cross-sectional study , 2017, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[486] H. Bundgaard,et al. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy. , 2017, JACC. Cardiovascular interventions.

[487] H. Calkins,et al. Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications , 2017, Journal of the American Heart Association.

[488] M. Link,et al. Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy. , 2017, American Journal of Cardiology.

[489] O. Alfieri,et al. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[490] A. Camm,et al. Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy. , 2017, Arrhythmia & electrophysiology review.

[491] Robert H. Anderson,et al. Key Questions Relating to Left Ventricular Noncompaction Cardiomyopathy: Is the Emperor Still Wearing Any Clothes? , 2017, The Canadian journal of cardiology.

[492] R. Chan,et al. Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients , 2017, Journal of the American Heart Association.

[493] A. von Eckardstein,et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome , 2017, European heart journal.

[494] P. Elliott,et al. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.

[495] Thor Edvardsen,et al. Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. , 2017, JACC. Cardiovascular imaging.

[496] H. Bundgaard,et al. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry , 2017, Journal of the American Heart Association.

[497] E. Nagel,et al. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. , 2017, Radiology.

[498] J. Uhm,et al. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy , 2017, Heart.

[499] L. Mestroni,et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy , 2017, Heart.

[500] T. Driscoll,et al. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications. , 2017, Circulation. Cardiovascular genetics.

[501] K. Siminovitch,et al. Prevalence and Clinical Implication of Double Mutations in Hypertrophic Cardiomyopathy: Revisiting the Gene-Dose Effect , 2017, Circulation. Cardiovascular genetics.

[502] M. Scheinman,et al. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. , 2017, Heart Rhythm.

[503] D. Corrado,et al. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study. , 2017, Heart Rhythm.

[504] M. Saeed,et al. Magnetic resonance imaging for characterizing myocardial diseases , 2017, The International Journal of Cardiovascular Imaging.

[505] W. Hua,et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy , 2017, Journal of geriatric cardiology : JGC.

[506] C. Silversides,et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis , 2017, European heart journal.

[507] Yeung Yam,et al. Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: A validation study and systematic review. , 2017, International journal of cardiology.

[508] M. Link,et al. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.

[509] Jason C. Rubenstein,et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator , 2017, New England Journal of Medicine.

[510] R. Barriales-Villa,et al. Nueva mutación fundadora en MYBPC3: comparación fenotípica con la mutación de MYBPC3 más frecuente en España , 2017 .

[511] Jeroen J. Bax,et al. Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation , 2017, Circulation. Arrhythmia and electrophysiology.

[512] R. Schiffmann,et al. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2017, Kidney international.

[513] J. Voigt,et al. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters. , 2017, Circulation. Cardiovascular imaging.

[514] A. Moorman,et al. Excessive trabeculations in noncompaction do not have the embryonic identity. , 2017, International journal of cardiology.

[515] Gilbert Habib,et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. , 2017, European heart journal cardiovascular Imaging.

[516] M. Shoda,et al. HotBalloon Ablation of the Pulmonary Veins for Paroxysmal AF: A Multicenter Randomized Trial in Japan. , 2016, Journal of the American College of Cardiology.

[517] Stuart A. Cook,et al. Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[518] R. Bellazzi,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk. , 2016, Journal of the American College of Cardiology.

[519] R. Hauer,et al. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2016, Cardiovascular Electrophysiology.

[520] M. Emdin,et al. Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy. , 2016, American Journal of Cardiology.

[521] R. Płoski,et al. Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy , 2016, American Journal of Medical Genetics. Part A.

[522] W. Stevenson,et al. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. , 2016, Journal of the American College of Cardiology.

[523] R. Omar,et al. Predictors of atrial fibrillation in hypertrophic cardiomyopathy , 2016, Heart.

[524] E. Arana-Rueda,et al. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[525] T. Aiba,et al. Potentially Lethal Ventricular Arrhythmias and Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy: What Are the Differences Between Men and Women? , 2016, JACC Clinical Electrophysiology.

[526] K. Ormond,et al. Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy , 2016, Open Heart.

[527] R. Oldenburg,et al. Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy. , 2016, American Journal of Cardiology.

[528] A. Dispenzieri,et al. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. , 2016, Journal of the American College of Cardiology.

[529] A. Bharatha,et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. , 2016, Journal of the American Medical Association (JAMA).

[530] R. Contri,et al. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives , 2016, European Journal of Heart Failure.

[531] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[532] J. Hartikainen,et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial , 2016, Heart.

[533] M. Rienstra,et al. Rate control in atrial fibrillation , 2016, The Lancet.

[534] John Everett Mumford,et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013 , 2016, British Medical Journal.

[535] A. Timperio,et al. Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers , 2016, Open Heart.

[536] M. Biagetti,et al. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in Hypertrophic Cardiomyopathy in a Reference Center in South America. , 2016, The American journal of cardiology.

[537] J. Pu,et al. Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy , 2016, Heart and Vessels.

[538] P. Noseworthy,et al. Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. , 2016, Journal of the American College of Cardiology.

[539] H. Smeets,et al. Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers. , 2016, European heart journal.

[540] James C Moon,et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.

[541] A. Hagège,et al. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. , 2016, European heart journal.

[542] S. Heymans,et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[543] G. Schuler,et al. Endomyocardial miR‐133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy , 2016, European Journal of Heart Failure.

[544] M. Desai,et al. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery , 2016, Heart.

[545] A. Green,et al. Family Communication in Inherited Cardiovascular Conditions in Ireland , 2016, Journal of Genetic Counseling.

[546] Peter Brønnum Nielsen,et al. Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study , 2016, Scientific Reports.

[547] M. Abel,et al. Safety of Noncardiac Surgery in Patients With Hypertrophic Obstructive Cardiomyopathy at a Tertiary Care Center. , 2016, Journal of Cardiothoracic and Vascular Anesthesia.

[548] R. Swaminathan,et al. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011. , 2016, JAMA cardiology.

[549] M. Eriksson,et al. Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic Cardiomyopathy , 2016, Circulation. Cardiovascular Interventions.

[550] F. Weidemann,et al. Longitudinal strain bull’s eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy , 2016, European Journal of Medical Research.

[551] L. Monserrat,et al. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. , 2016, The Journal of Heart and Lung Transplantation.

[552] L. Sposato,et al. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis. , 2016, Stroke.

[553] M. Link,et al. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry , 2016, Journal of cardiovascular electrophysiology.

[554] E. Behr,et al. Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. , 2016, Journal of the American College of Cardiology.

[555] Dhanunjaya R. Lakkireddy,et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.

[556] D. Panagiotakos,et al. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[557] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[558] Yi Shen,et al. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[559] M. Ng,et al. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease , 2016, Journal of Cardiovascular Magnetic Resonance.

[560] M. Blanchard,et al. Relationships Between Health Literacy and Genomics-Related Knowledge, Self-Efficacy, Perceived Importance, and Communication in a Medically Underserved Population , 2016, Journal of health communication.

[561] Stefan L. Zimmerman,et al. Fibrofatty Changes: Incidence at Cardiac MR Imaging in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. , 2016, Radiology.

[562] K. McGeechan,et al. Posttraumatic Stress and Prolonged Grief After the Sudden Cardiac Death of a Young Relative. , 2016, JAMA internal medicine.

[563] T. Ripoll-Vera,et al. Protocolo de actuación en las cardiopatías familiares: síntesis de recomendaciones y algoritmos de actuación , 2016 .

[564] P. Parfrey,et al. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy , 2016, Circulation. Arrhythmia and electrophysiology.

[565] B. Gersh,et al. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy , 2016, Journal of Cardiovascular Translational Research.

[566] K. Połatyńska,et al. Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling , 2016, Journal of Applied Genetics.

[567] M. Daly,et al. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study , 2016, Familial Cancer.

[568] T. Edvardsen,et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy , 2016, European heart journal cardiovascular Imaging.

[569] Christine E. Seidman,et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice , 2016, Science.

[570] J. Skinner,et al. Inpatient detection of cardiac-inherited disease: the impact of improving family history taking , 2016, Open Heart.

[571] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[572] C. Semsarian,et al. Factors influencing uptake of familial long QT syndrome genetic testing , 2016, American journal of medical genetics. Part A.

[573] J. Seidman,et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[574] L. Tavazzi,et al. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. , 2016, European heart journal.

[575] A. Patenaude,et al. The psychological impact of genetic information on children: a systematic review , 2016, Genetics in Medicine.

[576] A. Hagège,et al. X‐chromosome inactivation in female patients with Fabry disease , 2016, Clinical genetics.

[577] L. Mestroni,et al. Clinical Spectrum of PRKAG2 Syndrome , 2016, Circulation. Arrhythmia and electrophysiology.

[578] G. Filippatos,et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.

[579] Robert L Kormos,et al. Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[580] J. Petryka,et al. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy , 2015, Pediatric Cardiology.

[581] D. Lane,et al. Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials , 2015, European journal of heart failure.

[582] Chi Cai,et al. Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy , 2015, Journal of cardiovascular medicine.

[583] S. Tezenas du Montcel,et al. A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia. , 2015, JAMA neurology.

[584] P. Syrris,et al. Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy , 2015, Cardiovascular Electrophysiology.

[585] M. Senni,et al. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. , 2015, Journal of the American College of Cardiology.

[586] E. González-López,et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. , 2015, European heart journal.

[587] F. Gadler,et al. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery , 2015, Journal of cardiovascular electrophysiology.

[588] M. Ackerman,et al. Surgical Ventricular Septal Myectomy for Patients With Noonan Syndrome and Symptomatic Left Ventricular Outflow Tract Obstruction. , 2015, The American journal of cardiology.

[589] Dhanunjaya R. Lakkireddy,et al. Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation. , 2015, Journal of the American College of Cardiology.

[590] H. Bundgaard,et al. Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons , 2015, Circulation.

[591] P. Elliott,et al. Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinic , 2015, Cardiology in the Young.

[592] S. Klebe,et al. The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement. , 2015, International journal of cardiology.

[593] R. Mahajan,et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. , 2015, Journal of the American College of Cardiology.

[594] K. Phan,et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review , 2015, Journal of Interventional Cardiac Electrophysiology.

[595] J. Towbin,et al. Left ventricular non-compaction cardiomyopathy , 2015, The Lancet.

[596] H. Lambert,et al. Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study , 2015, Circulation.

[597] F. T. ten Cate,et al. Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.

[598] M. Link,et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement , 2015, European heart journal.

[599] R. Omar,et al. Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA) , 2015, European journal of heart failure.

[600] M. Link,et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.

[601] Liang-ping Zhao,et al. Long-term outcomes of catheter ablation of atrial fibrillation in dilated cardiomyopathy. , 2015, International Journal of Cardiology.

[602] B. Gelb,et al. Cardiomyopathies in Noonan syndrome and the other RASopathies. , 2015, Progress in pediatric cardiology.

[603] S. Day,et al. Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy. , 2015, Clinics in sports medicine.

[604] N. Smedira,et al. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2015, Heart rhythm.

[605] D. Popović,et al. Sudden Cardiac Death in Athletes. , 2015, European cardiology.

[606] A. Briasoulis,et al. Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis , 2015, Heart.

[607] J. Carlin,et al. Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. , 2015, Journal of the American College of Cardiology.

[608] Christopher X. Wong,et al. Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies. , 2015, JACC. Clinical electrophysiology.

[609] Stefan L. Zimmerman,et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members , 2015, Circulation. Cardiovascular genetics.

[610] Christopher X. Wong,et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[611] Prashanthan Sanders,et al. Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.

[612] J. Seidman,et al. Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain , 2015, Heart.

[613] T. Kubo,et al. Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. , 2015, Journal of cardiology.

[614] M. Josephson,et al. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. , 2015, Journal of the American College of Cardiology.

[615] V. Fuster,et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. , 2015, Journal of the American College of Cardiology.

[616] F. Salvi,et al. Cardiac amyloidosis: the great pretender , 2015, Heart Failure Reviews.

[617] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[618] A. Koeppen,et al. The Pathogenesis of Cardiomyopathy in Friedreich Ataxia , 2015, PloS one.

[619] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[620] Erwan Donal,et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. , 2015, European heart journal cardiovascular Imaging.

[621] B. Marino,et al. Health-Related Quality of Life Assessment in Children Followed in a Cardiomyopathy Clinic , 2015, Pediatric Cardiology.

[622] J. Pu,et al. Relation between N-terminal pro-brain natriuretic peptide and cardiac remodeling and function assessed by cardiovascular magnetic resonance imaging in patients with arrhythmogenic right ventricular cardiomyopathy. , 2015, The American journal of cardiology.

[623] A. Saguner,et al. Atrial arrhythmias in arrhythmogenic cardiomyopathy: at the beginning or at the end of the disease story? Reply. , 2015, Circulation Journal.

[624] Matthew S. Lebo,et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity , 2015, Genetics in Medicine.

[625] F. D’Antonio,et al. Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[626] E. Schwammenthal,et al. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: Results of a structured exercise training program in a cardiac rehabilitation center , 2015, European journal of preventive cardiology.

[627] Jeroen J. Bax,et al. Subclinical left ventricular dysfunction by echocardiographic speckle‐tracking strain analysis relates to outcome in sarcoidosis , 2015, European journal of heart failure.

[628] R. Mahajan,et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.

[629] N. Hagiwara,et al. Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm. , 2014, Journal of cardiology.

[630] A. Medeiros-Domingo,et al. Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[631] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[632] D. Bluemke,et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. , 2014, Journal of the American College of Cardiology.

[633] F. Callea,et al. Heart transplant and 2-year follow up in a child with generalized arterial calcification of infancy , 2014, European Journal of Pediatrics.

[634] C. Grines,et al. Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]). , 2014, The American journal of cardiology.

[635] M. Hubank,et al. Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy , 2014, Heart.

[636] T. Edvardsen,et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.

[637] E. I. Pierpont,et al. Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines , 2014, Pediatrics.

[638] Susanna Price,et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European heart journal.

[639] L. Mestroni,et al. Danon Disease: Clinical Features, Evaluation, and Management , 2014, Circulation: Heart Failure.

[640] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[641] J. Veselka,et al. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population. , 2014, European heart journal.

[642] E. Cook,et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[643] B. Thilaganathan,et al. Reversible De Novo Left Ventricular Trabeculations in Pregnant Women: Implications for the Diagnosis of Left Ventricular Noncompaction in Low-Risk Populations , 2014, Circulation.

[644] R. Hauer,et al. Outcome in Phospholamban R14del Carriers: Results of a Large Multicentre Cohort Study , 2014, Circulation. Cardiovascular genetics.

[645] M. Link,et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.

[646] D. Pennell,et al. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy , 2014, Heart.

[647] B. Gersh,et al. Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population , 2014, Journal of the American Heart Association.

[648] C. Semsarian,et al. Conveying a probabilistic genetic test result to families with an inherited heart disease. , 2014, Heart rhythm.

[649] J. Finsterer,et al. Repeated Radiofrequency Ablation of Atrial Tachycardia in Restrictive Cardiomyopathy Secondary to Myofibrillar Myopathy , 2014, Journal of cardiovascular electrophysiology.

[650] J. Austin,et al. Conceptualizing Genetic Counseling as Psychotherapy in the Era of Genomic Medicine , 2014, Journal of Genetic Counseling.

[651] M. Slaughter,et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.

[652] B. Maron,et al. Incidence and causes of sudden death in U.S. college athletes. , 2014, Journal of the American College of Cardiology.

[653] T. Edvardsen,et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[654] M. Ackerman,et al. Pathogeneses of Sudden Cardiac Death in National Collegiate Athletic Association Athletes , 2014, Circulation. Arrhythmia and electrophysiology.

[655] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[656] J. Healey,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. , 2014, JAMA.

[657] K. Gauvreau,et al. Cardiovascular disease in Noonan syndrome , 2014, Archives of Disease in Childhood.

[658] Sivakumar Gowrisankar,et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing , 2014, Genetics in Medicine.

[659] M. Francone. Role of Cardiac Magnetic Resonance in the Evaluation of Dilated Cardiomyopathy: Diagnostic Contribution and Prognostic Significance , 2014, ISRN radiology.

[660] Jamil Mayet,et al. A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) , 2014, Circulation. Arrhythmia and electrophysiology.

[661] D. Delurgio,et al. Phased RF ablation in persistent atrial fibrillation. , 2014, Heart Rhythm.

[662] W. Burchert,et al. Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients , 2014, The International Journal of Cardiovascular Imaging.

[663] P. J. Devereaux,et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. , 2014, Journal of the American College of Cardiology.

[664] Paul M. K. Gordon,et al. Titin mutation in familial restrictive cardiomyopathy. , 2014, International journal of cardiology.

[665] S. Colan,et al. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry , 2013, The Lancet.

[666] V. Fuster,et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. , 2013, Journal of the American College of Cardiology.

[667] J. Piccini,et al. Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry. , 2013, Journal of atrial fibrillation.

[668] Stefan L. Zimmerman,et al. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[669] H. Calkins,et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2013, Heart rhythm.

[670] Lluís Mont,et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[671] G. Gensini,et al. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[672] Dhanunjaya R. Lakkireddy,et al. Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Long-Term Outcomes and Mechanisms of Arrhythmia Recurrence , 2013, Circulation. Arrhythmia and electrophysiology.

[673] C. Semsarian,et al. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. , 2013, International journal of cardiology.

[674] R. Prager,et al. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial. , 2013, Journal of the American College of Cardiology.

[675] S. Russell,et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[676] F. Forastiere,et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre‐clinical (stage B) heart failure in the elderly. Results from ‘PREDICTOR’, a population based‐study in central Italy , 2013, European Journal of Heart Failure.

[677] Josef Stehlik,et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[678] J. Towbin,et al. Characteristics and outcomes of heart failure-related intensive care unit admissions in children with cardiomyopathy. , 2013, Journal of Cardiac Failure.

[679] P. Elliott,et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review , 2013, Heart.

[680] R. Giugliano,et al. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients , 2013, Heart.

[681] S. Ni,et al. Effect of magnetic nanoparticles on the performance of activated sludge treatment system. , 2013, Bioresource Technology.

[682] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.

[683] V. Kamperidis,et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[684] S. Ommen,et al. Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. , 2013, The Annals of thoracic surgery.

[685] W. Manning,et al. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.

[686] N. Simon. Treating complicated grief. , 2013, Journal of the American Medical Association (JAMA).

[687] R. Macleod,et al. Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer , 2013, European Journal of Human Genetics.

[688] N. Smedira,et al. Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction , 2013, Circulation.

[689] C. Watson,et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. , 2013, JAMA.

[690] F. Gaita,et al. Long‐Term Efficacy and Safety of Two Different Rhythm Control Strategies in Elderly Patients with Symptomatic Persistent Atrial Fibrillation , 2013, Cardiovascular Electrophysiology.

[691] M. Sherrid,et al. Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &bgr;-Blockade or Verapamil , 2013, Circulation. Heart failure.

[692] S. Colan,et al. Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular genetics.

[693] M. Link,et al. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. , 2013, Circulation.

[694] Y. Pinto,et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[695] Tom Wong,et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. , 2013, Journal of the American College of Cardiology.

[696] H. Watkins,et al. Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications , 2013, European Journal of Human Genetics.

[697] R. Kwong,et al. T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.

[698] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[699] J. Ruskin,et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. , 2013, Journal of the American College of Cardiology.

[700] M. Link,et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.

[701] L. Yeates,et al. Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young , 2013, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[702] A. Zwinderman,et al. Gender‐specific differences in major cardiac events and mortality in lamin A/C mutation carriers , 2013, European journal of heart failure.

[703] A. Bassett,et al. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43 , 2013, Clinical genetics.

[704] E. Ashley,et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[705] R. Hall,et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. , 2013, European heart journal.

[706] A. Dawnay,et al. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. , 2013, European heart journal.

[707] A. Flett,et al. Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance , 2013, Journal of Cardiovascular Magnetic Resonance.

[708] Matt Reed,et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? , 2013, Heart.

[709] B. Gersh,et al. Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope. , 2013, American Journal of Cardiology.

[710] J. Allanson,et al. Noonan syndrome , 2013, The Lancet.

[711] S. Ommen,et al. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. , 2013, Annals of Thoracic Surgery.

[712] K. Siminovitch,et al. Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.

[713] M. Masè,et al. Autosomal Recessive Atrial Dilated Cardiomyopathy With Standstill Evolution Associated With Mutation of Natriuretic Peptide Precursor A , 2013, Circulation. Cardiovascular genetics.

[714] K. Nasir,et al. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. , 2012, The Journal of Heart and Lung Transplantation.

[715] R. Hauer,et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[716] B. Gersh,et al. Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2012, Circulation.

[717] R. Hauer,et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[718] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[719] Gerhard Hindricks,et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2012, The New England journal of medicine.

[720] J. Noonan,et al. Cardiac findings in Noonan syndrome on long-term follow-up. , 2012, Congenital Heart Disease.

[721] S. Colan,et al. Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype: A Report From the Pediatric Cardiomyopathy Registry , 2012, Circulation.

[722] S. Colan,et al. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. , 2012, American heart journal.

[723] E. Nagel,et al. Letter by Puntmann et al regarding article, "Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy". , 2012, Circulation. Cardiovascular imaging.

[724] A. Zwinderman,et al. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. , 2013, International journal of cardiology.

[725] R. Falk,et al. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). , 2012, American heart journal.

[726] J. Hoffmann,et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies , 2012, European Radiology.

[727] G. R. Wagner,et al. Cardiomyopathy in Friedreich Ataxia , 2012, Journal of Child Neurology.

[728] H. Chubb,et al. The use of Z-scores in paediatric cardiology , 2012, Annals of Pediatric Cardiology.

[729] M. Abel,et al. Transapical Approach for Apical Myectomy and Relief of Midventricular Obstruction in Hypertrophic Cardiomyopathy , 2012, Journal of cardiac surgery.

[730] Niels Keiding,et al. Thrombotic stroke and myocardial infarction with hormonal contraception. , 2012, The New England journal of medicine.

[731] T. Edvardsen,et al. Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[732] D. Pennell,et al. Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major , 2012, Haematologica.

[733] S. Ommen,et al. Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis. , 2012, JACC. Cardiovascular interventions.

[734] James D. Thomas,et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.

[735] B. Firwana,et al. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy. , 2012, The Cochrane database of systematic reviews.

[736] S. Ommen,et al. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. , 2012, American Journal of Cardiology.

[737] P. Scuffham,et al. Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life , 2012, Genetics in Medicine.

[738] T. Kristensen,et al. Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis. , 2012, European Journal of Radiology.

[739] J. Towbin,et al. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. , 2012, Journal of cardiac failure.

[740] A. Gavazzi,et al. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy , 2012, European heart journal.

[741] R. Ross. The Ross Classification for Heart Failure in Children After 25 Years: A Review and an Age-Stratified Revision , 2012, Pediatric Cardiology.

[742] G. Sutherland,et al. The Heart in Friedreich Ataxia: Definition of Cardiomyopathy, Disease Severity, and Correlation With Neurological Symptoms , 2012, Circulation.

[743] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[744] A. Wilde,et al. Clinical assessment of the development of hypertrophic cardiomyopathy by cardiovascular magnetic resonance imaging , 2013 .

[745] D. Dingli,et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[746] P. Sanders,et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. , 2012, European Heart Journal.

[747] R. M. Payne,et al. Cardiomyopathy of Friedreich’s Ataxia (FRDA) , 2012, Irish Journal of Medical Science.

[748] L. Mestroni,et al. Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[749] Robert A. deKemp,et al. The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.

[750] H. Calkins,et al. General and Disease-Specific Psychosocial Adjustment in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy With Implantable Cardioverter Defibrillators: A Large Cohort Study , 2012, Circulation. Cardiovascular genetics.

[751] A. Zwinderman,et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[752] D. Corrado,et al. Prevalence of Cardiomyopathy in Italian Asymptomatic Children With Electrocardiographic T-Wave Inversion at Preparticipation Screening , 2012, Circulation.

[753] Thomas J. Wang,et al. Cardiac arrest during long-distance running races. , 2012, The New England journal of medicine.

[754] D. Atar,et al. Dronedarone in high-risk permanent atrial fibrillation. , 2011, The New England journal of medicine.

[755] L. Yeates,et al. The emerging role of the cardiac genetic counselor. , 2011, Heart Rhythm.

[756] Mario Baldi,et al. Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy: A Prospective, Randomized, 4-Year Follow-Up Trial: The APAF Study , 2011, Circulation. Arrhythmia and electrophysiology.

[757] P. Scuffham,et al. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy , 2011, Heart.

[758] J. Towbin,et al. Conduction Abnormalities in Pediatric Patients With Restrictive Cardiomyopathy , 2011, Circulation. Heart failure.

[759] D. Brito,et al. From hypertrophic cardiomyopathy centers to inherited cardiovascular disease centers in Europe. A small or a major step? A position paper from the Nucleus of the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology. , 2011, Revista Portuguesa de Cardiologia.

[760] S. Russell,et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. , 2011, Journal of the American College of Cardiology.

[761] P. Elliott,et al. Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey , 2011, Heart.

[762] T. Kubo,et al. Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[763] F. Berger,et al. Sarcomere Gene Mutations in Isolated Left Ventricular Noncompaction Cardiomyopathy Do Not Predict Clinical Phenotype , 2011, Circulation. Cardiovascular genetics.

[764] A. Folsom,et al. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. , 2011, Heart Rhythm.

[765] P. Lambiase,et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy , 2011, Heart.

[766] R. Kim,et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.

[767] J. Lötjönen,et al. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[768] B. Yashiro,et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[769] P. Pieper,et al. Systematic review of pregnancy in women with inherited cardiomyopathies , 2011, European journal of heart failure.

[770] N. Hagiwara,et al. Risk of sudden death in end-stage hypertrophic cardiomyopathy. , 2011, Journal of cardiac failure.

[771] K. Dou,et al. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review. , 2011, Chinese medical journal.

[772] R. von Känel,et al. Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. , 2011, Journal of affective disorders.

[773] J. Allanson,et al. Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype? , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

[774] A. Koeppen. Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics , 2011, Journal of the Neurological Sciences.

[775] E. Leifer,et al. Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events , 2011, Pediatric Cardiology.

[776] R. Tenconi,et al. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C , 2011, American journal of medical genetics. Part A.

[777] W. Dreyer,et al. Restrictive Physiology is Associated With Poor Outcomes in Children With Hypertrophic Cardiomyopathy , 2011, Pediatric Cardiology.

[778] S. Perlman,et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). , 2011, American heart journal.

[779] Nick Freemantle,et al. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[780] S. Raman,et al. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. , 2011, European heart journal.

[781] S. Day,et al. Psychological Issues in Genetic Testing for Inherited Cardiovascular Diseases , 2011, Circulation. Cardiovascular genetics.

[782] B. Gelb,et al. Noonan syndrome and clinically related disorders. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[783] A. Oto,et al. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy. , 2011, Journal of interventional cardiology.

[784] M. Schloesser,et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. , 2011, Journal of the American College of Cardiology.

[785] J. Brugada,et al. Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training , 2011, Circulation.

[786] M. Ackerman,et al. Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy Response by Ho on P 2450 Controversies in Cardiovascular Medicine , 2022 .

[787] Matthew R. G. Taylor,et al. Functional performance and muscle strength phenotypes in men and women with Danon disease , 2010, Muscle & nerve.

[788] A. Rynkiewicz,et al. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. , 2010, European heart journal.

[789] B. Gelb,et al. Disorders of dysregulated signal traffic through the RAS‐MAPK pathway: phenotypic spectrum and molecular mechanisms , 2010, Annals of the New York Academy of Sciences.

[790] Florence Dumas,et al. Sports-Related Sudden Death in the General Population , 2010, Circulation.

[791] D. Germain. Fabry disease , 2010, Orphanet journal of rare diseases.

[792] L. Tavazzi,et al. When should cardiologists suspect Anderson-Fabry disease? , 2010, The American journal of cardiology.

[793] J. McMurray,et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial , 2010, Heart.

[794] A. Keren,et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[795] J. Allanson,et al. Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines , 2010, Pediatrics.

[796] J. Svendsen,et al. Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening. , 2010, Heart rhythm.

[797] A. Camm,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[798] J. Towbin. Left ventricular noncompaction: a new form of heart failure. , 2010, Heart failure clinics.

[799] M. Link,et al. Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia , 2010, Circulation.

[800] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[801] C. Upasani,et al. Perioperative anesthetic management of patients with hypertrophic cardiomyopathy for noncardiac surgery: a case series. , 2010, Annals of cardiac anaesthesia.

[802] F. Marchlinski,et al. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia. , 2010, The American journal of cardiology.

[803] R. Frank,et al. C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia , 2010, Cardiology Research and Practice.

[804] I. Kowalik,et al. Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.

[805] S. Perlman,et al. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. , 2010, Archives of neurology.

[806] R. Barriales-Villa,et al. Trastornos graves de la conducción cardiaca e implante de marcapasos en pacientes con miocardiopatía hipertrófica , 2010 .

[807] F. T. ten Cate,et al. The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.

[808] P. Serruys,et al. Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy: A Word of Caution , 2010, Circulation. Heart failure.

[809] Gilbert Habib,et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.

[810] A. Pestronk,et al. A randomized study of alglucosidase alfa in late-onset Pompe's disease. , 2010, The New England journal of medicine.

[811] Otto Kamp,et al. Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[812] K. Sliwa,et al. Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study , 2010, Circulation.

[813] H. Watkins,et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.

[814] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[815] Y. Pinto,et al. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[816] D. Simel,et al. Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy: Comparative Rates of Overall Mortality and Sudden Cardiac Death After Treatment , 2010, Circulation. Cardiovascular interventions.

[817] Michel Haissaguerre,et al. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[818] P. Stetson,et al. Perioperative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. , 2010, Congestive Heart Failure.

[819] N. Smedira,et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[820] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.

[821] Burr Hall,et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[822] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[823] S. Siu,et al. Pregnancy outcomes in women with dilated cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[824] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[825] G. Boriani,et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[826] P. Lambiase,et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. , 2009, European heart journal.

[827] J. Moolman-Smook,et al. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. , 2009, Heart rhythm.

[828] I. V. Van Gelder,et al. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. , 2009, Heart rhythm.

[829] S. Yusuf,et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. , 2009, Journal of the American College of Cardiology.

[830] S. Day,et al. Exercise in Hypertrophic Cardiomyopathy , 2009, Journal of Cardiovascular Translational Research.

[831] F. Salvi,et al. Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types , 2009, Circulation.

[832] G. Giannakoulas,et al. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[833] M. Sherrid,et al. Severe Symptoms in Mid and Apical Hypertrophic Cardiomyopathy , 2009, Echocardiography.

[834] G. Marcus,et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.

[835] A. García-Alberola,et al. Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic. , 2009, American Journal of Cardiology.

[836] B. Gersh,et al. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. , 2009, Journal of the American College of Cardiology.

[837] N. Smedira,et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[838] M. Sheppard,et al. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study , 2009, Heart.

[839] N. Lakkis,et al. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. , 2009, European heart journal.

[840] E. Arbustini,et al. Restrictive cardiomyopathy , 2009, Current opinion in cardiology.

[841] D. Sorysz,et al. Left Ventricular Outflow Tract Gradient Provoked by Upright Position or Exercise in Treated Patients with Hypertrophic Cardiomyopathy without Obstruction at Rest , 2009, Echocardiography.

[842] Amy Daly,et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. , 2009, Journal of the American College of Cardiology.

[843] C. Autore,et al. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy , 2009, Circulation.

[844] J. Seidman,et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. , 2009, JAMA.

[845] B. Gersh,et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy , 2009, Heart.

[846] A. Clarke,et al. Genetic testing in asymptomatic minorsBackground considerations towards ESHG Recommendations , 2009, European Journal of Human Genetics.

[847] B. Byrne,et al. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease , 2009, Genetics in Medicine.

[848] J. Schulz-Menger,et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. , 2009, Journal of the American College of Cardiology.

[849] C. Tondo,et al. Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy , 2009, Cardiovascular Electrophysiology.

[850] Dudley J Pennell,et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[851] F. Sacher,et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.

[852] G. Di Salvo,et al. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes , 2008, Cardiology in the Young.

[853] C. Tondo,et al. Diagnostic Value of Endomyocardial Biopsy Guided by Electroanatomic Voltage Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2008, Cardiovascular Electrophysiology.

[854] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[855] A. Reuser,et al. Pompe's disease , 2008, The Lancet.

[856] L. Tavazzi,et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.

[857] W. Manning,et al. Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[858] S. Nagueh,et al. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. , 2008, JACC. Cardiovascular interventions.

[859] S. Ommen,et al. Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[860] B. Meiser,et al. Assessment of the Content and Process of Genetic Counseling: A Critical Review of Empirical Studies , 2008, Journal of Genetic Counseling.

[861] P. Elliott,et al. Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy , 2008, Circulation. Cardiovascular genetics.

[862] Warren J Manning,et al. Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.

[863] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[864] F. Flachskampf,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[865] Wei Du,et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[866] Margaret L. Karst,et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology , 2008, Clinical genetics.

[867] B. Gersh,et al. Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.

[868] J. McMurray,et al. Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[869] F. Berger,et al. Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction , 2008, Circulation.

[870] D. Hagler,et al. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[871] A. Einstein,et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. , 2008, Chest.

[872] N. Sebire,et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.

[873] Eugene H Blackstone,et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. , 2008, The Annals of thoracic surgery.

[874] D. Holmgren,et al. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. , 2008, European heart journal.

[875] Heidi L Rehm,et al. Shared genetic causes of cardiac hypertrophy in children and adults. , 2008, The New England journal of medicine.

[876] Sean Connors,et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.

[877] J Dundon,et al. Interventions to improve risk communication in clinical genetics: systematic review. , 2008, Patient education and counseling.

[878] C. Stellbrink,et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience , 2008, Clinical Research in Cardiology.

[879] G. Whyte,et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. , 2008, Journal of the American College of Cardiology.

[880] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[881] G. Di Salvo,et al. Genotype–phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome , 2008, American journal of medical genetics. Part A.

[882] R. Brady,et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease , 2008, Proceedings of the National Academy of Sciences.

[883] G. Boriani,et al. Heart transplantation in hypertrophic cardiomyopathy. , 2008, American Journal of Cardiology.

[884] P. Phongsavan,et al. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy , 2008, Genetics in Medicine.

[885] L. Trinquart,et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. , 2008, European heart journal.

[886] J. Potter,et al. A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin* , 2008, Journal of Biological Chemistry.

[887] P. Vestergaard,et al. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis , 2008, Heart.

[888] S. Ommen,et al. Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization , 2007, Circulation.

[889] A. Keren,et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy , 2007, Heart.

[890] R. Passman,et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. , 2007, Archives of Internal Medicine.

[891] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[892] S. Mital,et al. Twenty‐Year Experience With Heart Transplantation for Infants and Children With Restrictive Cardiomyopathy: 1986–2006 , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[893] S. Kunimoto,et al. Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy Associated with an Apical Aneurysm: Evaluation of Possible Causes of Aneurysm Formation , 2007, Yonsei medical journal.

[894] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[895] K. Fischbeck,et al. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial , 2007, The Lancet Neurology.

[896] D. Fassbender,et al. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response , 2007, Clinical Research in Cardiology.

[897] M. Frenneaux,et al. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[898] B. Gersh,et al. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience , 2007, Nature Clinical Practice Cardiovascular Medicine.

[899] Javed Butler,et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. , 2007, Journal of the American College of Cardiology.

[900] P. Bauer,et al. Cardiomyopathy in Friedreich's ataxia‐assessment by cardiac MRI , 2007, Movement disorders : official journal of the Movement Disorder Society.

[901] G. Di Salvo,et al. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. , 2007, The American journal of cardiology.

[902] M. Link,et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.

[903] M. Aguilar,et al. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. , 2007 .

[904] D. Fassbender,et al. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. , 2007, International journal of cardiology.

[905] K. Zingmark,et al. Supportive needs of parents confronted with sudden cardiac death--a qualitative study. , 2007, Resuscitation.

[906] P. Elliott,et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.

[907] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[908] M. ROTH-KLEINER,et al. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. , 2007, European heart journal.

[909] P. Shiels,et al. Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy. , 2007, The Journal of invasive cardiology.

[910] F. Gaita,et al. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.

[911] B. Maron,et al. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy , 2007, Heart.

[912] J. Zamorano,et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. , 2007, European Heart Journal.

[913] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[914] S. Colan,et al. Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2007, Circulation.

[915] W. Hwu,et al. Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease , 2007 .

[916] Y. Pinto,et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. , 2006, Journal of the American College of Cardiology.

[917] V. Santinelli,et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[918] B. Maron,et al. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. , 2006, American Journal of Cardiology.

[919] P. Elliott,et al. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. , 2006, European heart journal.

[920] M. Link,et al. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[921] H. Crijns,et al. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[922] C. Alpers,et al. Iatrogenic phospholipidosis mimicking Fabry disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[923] S. Colan,et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[924] Maurizio Schiavon,et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.

[925] S. Russell,et al. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[926] B. Maron,et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.

[927] M. Janabi,et al. Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania , 2006, Tropical doctor.

[928] M. Patton,et al. The natural history of Noonan syndrome: a long-term follow-up study , 2006, Archives of Disease in Childhood.

[929] J. Pu,et al. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis. , 2006, International Journal of Cardiology.

[930] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[931] W. Manning,et al. Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[932] J. Brugada,et al. Familial Pseudo‐Wolff‐Parkinson‐White Syndrome , 2006, Cardiovascular Electrophysiology.

[933] M. Pfeffer,et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[934] P. Calabrò,et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[935] M. Dew,et al. Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[936] S. Idriss,et al. Electrocardiographic response to enzyme replacement therapy for Pompe disease , 2006, Genetics in Medicine.

[937] Wuh-Liang Hwu,et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, Jornal de Pediatria.

[938] M. Russo,et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. , 2006, Journal of the American College of Cardiology.

[939] R. Bennett,et al. A New Definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force Report , 2006, Journal of Genetic Counseling.

[940] L. Leinwand,et al. Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy , 2006, Circulation research.

[941] Frank Bogun,et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[942] R. Berger,et al. Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy? , 2006, Circulation.

[943] R. Hennekam,et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome , 2006, Nature Genetics.

[944] M. Elliott,et al. Heart and heart–lung transplantation for idiopathic restrictive cardiomyopathy in children , 2005, Heart.

[945] D. Holmgren,et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly , 2005, Cardiology in the Young.

[946] Seok‐Min Kang,et al. Tissue Doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy. , 2005, Chest.

[947] W. Mckenna,et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.

[948] F. Salvi,et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.

[949] E. Kasper,et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. , 2005, American heart journal.

[950] Christine E Seidman,et al. The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.

[951] A. Tajik,et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[952] M. Link,et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[953] M. Aguilar,et al. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. , 2005, The Cochrane database of systematic reviews.

[954] Stefan Neubauer,et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[955] Sabino Iliceto,et al. Three-Dimensional Electroanatomic Voltage Mapping Increases Accuracy of Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2005, Circulation.

[956] W. Mckenna,et al. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy , 2005, Heart.

[957] Mandeep Bhargava,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[958] W. Williams,et al. Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy , 2005, Circulation.

[959] B. Maron,et al. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. , 2005, Journal of the American College of Cardiology.

[960] B. Maron,et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[961] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[962] C. Autore,et al. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. , 2005, Journal of the American College of Cardiology.

[963] H. Calkins,et al. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. , 2005, Journal of the American College of Cardiology.

[964] P. Elliott,et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. , 2005, Journal of the American College of Cardiology.

[965] J. Seidman,et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. , 2005, The New England journal of medicine.

[966] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[967] S. Peters,et al. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. , 2004, International journal of cardiology.

[968] T. Yokoyama,et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[969] J. Schulz-Menger,et al. Percutaneous Transluminal Septal Artery Ablation Using Polyvinyl Alcohol Foam Particles for Septal Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy: Acute and 3-Year Outcomes , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[970] X. Jouven,et al. Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Circulation.

[971] M. Chiariello,et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[972] I. Ţintoiu,et al. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. , 2004, Kardiologia polska.

[973] S. Mickelsen,et al. Doppler Evaluation of the Descending Aorta in Patients with Hypertrophic Cardiomyopathy: Potential for Assessing the Functional Significance of Outflow Tract Gradients and for Optimizing Pacemaker Function , 2004, Journal of Interventional Cardiac Electrophysiology.

[974] N. Protonotarios,et al. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[975] Dudley J Pennell,et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[976] B. Maron,et al. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). , 2004, The American journal of cardiology.

[977] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[978] D. Pennell,et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[979] Z. Tran,et al. Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. , 2004, Preventive medicine.

[980] R. Hruban,et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. , 2004, American heart journal.

[981] J. Towbin,et al. Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy , 2004, Circulation.

[982] B. Franklin,et al. Exercise and Hypertension , 2004 .

[983] N. Smedira,et al. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[984] B. Maron,et al. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. , 2004, The Journal of thoracic and cardiovascular surgery.

[985] M. Link,et al. Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[986] B. Maron,et al. From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy , 2003, Heart.

[987] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[988] D. Pennell,et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.

[989] J. Belmont,et al. Clinical Characterization of Left Ventricular Noncompaction in Children: A Relatively Common Form of Cardiomyopathy , 2003, Circulation.

[990] A. Tajik,et al. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease , 2003, Circulation.

[991] I-Min Lee,et al. Physical activity and cancer prevention--data from epidemiologic studies. , 2003, Medicine and science in sports and exercise.

[992] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[993] W. Hop,et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. , 2003, Pediatrics.

[994] B. Maron,et al. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.

[995] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[996] R. Krittayaphong,et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[997] John B Carlin,et al. The epidemiology of childhood cardiomyopathy in Australia. , 2003, The New England journal of medicine.

[998] E John Orav,et al. The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[999] F. T. ten Cate,et al. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.

[1000] E. Holme,et al. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. , 2003, European heart journal.

[1001] B. Maron,et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[1002] P. Elliott,et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.

[1003] M. Dixit,et al. Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-up , 2002, BMC nephrology.

[1004] C. Sköld,et al. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography , 2002, Journal of internal medicine.

[1005] Meir J. Stampfer,et al. Exercise type and intensity in relation to coronary heart disease in men , 2002 .

[1006] A. Tajik,et al. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[1007] J. Conti,et al. QUALITY OF LIFE AND PSYCHOLOGICAL FUNCTIONING OF ICD PATIENTS , 2002, Heart.

[1008] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[1009] B. Maron,et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[1010] Michael A. Patton,et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.

[1011] B. Maron,et al. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[1012] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[1013] W. Shen,et al. Role of Programmed Ventricular Stimulation and Implantable Cardioverter Defibrillators in Patients with Idiopathic Dilated Cardiomyopathy and Syncope , 2001, Pacing and clinical electrophysiology : PACE.

[1014] B. Biesecker. Goals of genetic counseling , 2001, Clinical genetics.

[1015] Glen P. Kenny,et al. Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials , 2001 .

[1016] S. Michie,et al. Predictive genetic testing in children and adults: a study of emotional impact , 2001, Journal of medical genetics.

[1017] S. Siu,et al. Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease , 2001, Circulation.

[1018] L. Fananapazir,et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. , 2001, The New England journal of medicine.

[1019] T. Haider,et al. The Mount Sinai Hospital clinicalpathological conference: a 45-year-old man with Pompe's disease and dilated cardiomyopathy. , 2001, The Mount Sinai journal of medicine, New York.

[1020] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[1021] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[1022] S. Connolly,et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[1023] W. Williams,et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. , 2000, Journal of the American College of Cardiology.

[1024] S. Dimauro,et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.

[1025] J. Towbin,et al. Sudden Death and Cardiovascular Collapse in Children With Restrictive Cardiomyopathy , 2000 .

[1026] R. Cappato,et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[1027] J. Daubert,et al. Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. , 2000, Journal of molecular and cellular cardiology.

[1028] A. Crosby,et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[1029] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[1030] C. Wippermann,et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[1031] J B Seward,et al. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. , 2000, Circulation.

[1032] B. Silverman,et al. Cardiovascular effects of growth hormone , 2000, Endocrine.

[1033] M Gent,et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[1034] M. Decristofaro,et al. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function. , 2000, The Canadian journal of cardiology.

[1035] W. Chan,et al. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. , 2000, Archives of internal medicine.

[1036] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[1037] E. Storey,et al. Clinical and genetic study of Friedreich ataxia in an Australian population. , 1999, American journal of medical genetics.

[1038] T. Riesenfeld,et al. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. , 1999, Journal of the American College of Cardiology.

[1039] J. Stauffer,et al. Subaortic obstruction after sildenafil in a patient with hypertrophic cardiomyopathy. , 1999, The New England journal of medicine.

[1040] A. Munnich,et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.

[1041] K. Borisov,et al. Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy , 1999, The Thoracic and cardiovascular surgeon.

[1042] M. Komajda,et al. Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy , 1999, Journal of medical genetics.

[1043] M. Josephson,et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.

[1044] B. Maron,et al. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. , 1999, Journal of the American College of Cardiology.

[1045] P. Elliott,et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[1046] B. McCrindle,et al. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[1047] T. Imaizumi,et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[1048] L. Carvajal-Huerta. Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. , 1998, Journal of the American Academy of Dermatology.

[1049] José A. Sobrino,et al. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. , 1998, Circulation.

[1050] Asso,et al. Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[1051] A. Kisanuki,et al. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. , 1998, Circulation.

[1052] S. Colan,et al. Verapamil therapy in infants with hypertrophic cardiomyopathy , 1998, Cardiology in the Young.

[1053] O. Hess,et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. , 1998, The Annals of thoracic surgery.

[1054] B. Maron,et al. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[1055] S. Goldhaber,et al. Anticoagulation in dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[1056] T. Meitinger,et al. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes , 1998, Human Genetics.

[1057] E. Arbustini,et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. , 1998, Journal of the American College of Cardiology.

[1058] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[1059] W. Mckenna,et al. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[1060] O. Simell,et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.

[1061] W. Mckenna,et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. , 1997, European heart journal.

[1062] H. Watkins,et al. Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.

[1063] S. Michie,et al. Genetic counselling: the psychological impact of meeting patients' expectations. , 1997, Journal of medical genetics.

[1064] A. Tajik,et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. , 1997, Journal of the American College of Cardiology.

[1065] A. Angelini,et al. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. , 1996, Heart.

[1066] A Dürr,et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[1067] G Campanella,et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.

[1068] A. Tajik,et al. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. , 1996, Circulation.

[1069] David,et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. , 1996, Journal of the American College of Cardiology.

[1070] F. Casazza,et al. The varying evolution of Friedreich's ataxia cardiomyopathy. , 1996, The American journal of cardiology.

[1071] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[1072] R. Robbins,et al. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. , 1996, The Journal of thoracic and cardiovascular surgery.

[1073] T. Katori,et al. Cardiovascular abnormalities in Noonan syndrome: The clinical findings and treatments , 1996, Acta paediatrica Japonica : Overseas edition.

[1074] A. Camm,et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. , 1996, Heart.

[1075] B. Maron,et al. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[1076] F. Flachskampf,et al. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. , 1995, Circulation.

[1077] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[1078] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[1079] U. Sigwart. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.

[1080] David P Miller,et al. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results , 1995 .

[1081] S. Ito,et al. Transesophageal echocardiographic evaluation of mitral regurgitation in hypertrophic cardiomyopathy: contributions of eccentric left ventricular hypertrophy and related abnormalities of the mitral complex. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[1082] J. Thomas,et al. Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. , 1995, The American journal of cardiology.

[1083] M. Domanski,et al. Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods. , 1995, The American journal of cardiology.

[1084] B. Maron,et al. Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse , 1994 .

[1085] R. Goldberg,et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. , 1993, The New England journal of medicine.

[1086] R. Falk,et al. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. , 1993, Chest.

[1087] J. Towbin,et al. X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[1088] N. Sigfússon,et al. The prevalence of hypertrophic cardiomyopathy in men: an echocardiographic population screening study with a review of death records , 1992, Journal of internal medicine.

[1089] B. Maron,et al. Initial Results of Combined Anterior Mitral Leaflet Plication and Ventricular Septal Myotomy‐Myectomy for Relief of Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy , 1992, Circulation.

[1090] E. Rosenkranz,et al. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.

[1091] W. Williams,et al. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. , 1992, Journal of the American College of Cardiology.

[1092] G. Breithardt,et al. Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.

[1093] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[1094] E. Arbustini,et al. H and L ferritins in myocardium in iron overload. , 1991, The American journal of cardiology.

[1095] D. Webb,et al. Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy , 1991, Circulation.

[1096] K. Ohno,et al. Mitochondrial mutation in fatal infantile cardiomyopathy , 1990, The Lancet.

[1097] M. Frenneaux,et al. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.

[1098] S. Morioka,et al. [Effects of plasminogen activator on epidermal cell migration]. , 1990, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology.

[1099] M. Frenneaux,et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[1100] F. Romeo,et al. Long‐Term prognosis in children with hypertrophic cardiomyopathy: An analysis of 37 patients aged ≤ 14 years at diagnosis , 1990, Clinical cardiology.

[1101] L. Melton,et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[1102] Z. Krajcer,et al. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. , 1989, Circulation.

[1103] B. Maron,et al. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.

[1104] R. Bonow,et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. , 1989, Circulation.

[1105] W. Mckenna,et al. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm. , 1989, British heart journal.

[1106] M. Cerqueira,et al. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. , 1988, Journal of vascular surgery.

[1107] K. Peterson,et al. Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.

[1108] D. Corrado,et al. Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[1109] M. Webb-Peploe,et al. Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy. , 1986, British heart journal.

[1110] Y. Koga,et al. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study. , 1986, Japanese heart journal.

[1111] B. Maron,et al. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. , 1986, Journal of the American College of Cardiology.

[1112] H. Rakowski,et al. Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction to left ventricular outflow. , 1986, Postgraduate medical journal.

[1113] J S Child,et al. Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. , 1986, Journal of the American College of Cardiology.

[1114] A. Castellanos,et al. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[1115] J. Opitz,et al. Noonan syndrome: a review. , 1985, American journal of medical genetics.

[1116] W. Williams,et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[1117] J. Dussaule,et al. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study. , 1985, American heart journal.

[1118] C. Oakley,et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[1119] R. Bonow,et al. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.

[1120] D. Siscovick,et al. The incidence of primary cardiac arrest during vigorous exercise. , 1984, The New England journal of medicine.

[1121] J. Deanfield,et al. Hypertrophic cardiomyopathy: an important cause of sudden death. , 1984, Archives of disease in childhood.

[1122] R. Ackroyd,et al. Friedreich's ataxia. A clinical review with neurophysiological and echocardiographic findings. , 1984, Archives of disease in childhood.

[1123] R. Bonow,et al. The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy. , 1983, European heart journal.

[1124] W. McKenna,et al. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. , 1983, Journal of the American College of Cardiology.

[1125] A. Rocchini,et al. Hemodynamic Effects of Verapamil in Children and Adolescents with Hypertrophic Cardiomyopathy , 1983, Circulation.

[1126] J. Goodwin,et al. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. , 1982, British heart journal.

[1127] S. Epstein,et al. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. , 1981, Circulation.

[1128] A. Harding. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. , 1981, Brain : a journal of neurology.

[1129] J. Gottdiener,et al. Hypertrophic Cardiomyopathy with Unusual Locations of Left Ventricular Hypertrophy Undetectable, by M‐mode Echocardiography: Identification by Wide‐angle Two‐dimensional Echocardiography , 1981, Circulation.

[1130] M. Davies,et al. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. , 1980, British heart journal.

[1131] B. Maron,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. , 1979, Circulation.

[1132] G. Jackson,et al. Asymmetric septal hypertrophy and propranolol treatment in a case of Ullrich-Noonan syndrome. , 1979, British heart journal.

[1133] J. Bouchard,et al. Clinical Description and Roentgenologic Evaluation of Patients with Friedreich's Ataxia , 1976, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[1134] R. Leachman,et al. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients. , 1976, The Journal of cardiovascular surgery.

[1135] W. Henry,et al. Operative Treatment in Hypertrophic Subaortic Stenosis: Techniques, and the Results of Pre and Postoperative Assessments in 83 Patients , 1975, Circulation.

[1136] P. Gillette,et al. Electrophysiological mechanism of the short PR interval in Pompe disease. , 1974, American journal of diseases of children.

[1137] M. Dunn,et al. Anterior‐Superior Displacement of Papillary Muscles Producing Obstruction and Mitral Regurgitation in Idiopathic Hypertrophic Subaortic Stenosis: Operative Relief by Posterior‐Superior Realignment of Papillary Muscles Following Ventricular Septal Myectomy , 1974, Circulation.

[1138] R. Balcon,et al. Syncope in hypertrophic obstructive cardiomyopathy due to asystole. , 1972, British heart journal.

[1139] R. Gramiak,et al. Long-term propranolol therapy in muscular subaortic stenosis. , 1970, British heart journal.

[1140] E. W. Hancock,et al. Muscular Subaortic Stenosis: Prevention of Outflow Obstruction with Propranolol , 1968, Circulation.

[1141] E. Wigle,et al. Muscular Subaortic Stenosis: The Direct Relation Between the Intraventricular Pressure Difference and the Left Ventricular Ejection Time , 1967, Circulation.

[1142] C. Lambrew,et al. Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[1143] P A Raffle,et al. Coronary heart-disease and physical activity of work. , 1953, Lancet.

[1144] OUP accepted manuscript , 2022, European Heart Journal - Quality of Care and Clinical Outcomes.

[1145] OUP accepted manuscript , 2022, Europace.

[1146] OUP accepted manuscript , 2021, European Heart Journal.

[1147] OUP accepted manuscript , 2021, European Heart Journal.

[1148] OUP accepted manuscript , 2021, Europace.

[1149] G. Lip,et al. Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients , 2021, Thrombosis and Haemostasis.

[1150] R. McGrath,et al. Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death. , 2019, International journal of cardiology.

[1151] Stefan L. Zimmerman,et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy , 2019 .

[1152] Adrian Baranchuk,et al. Atrial fibrillation in patients with inherited cardiomyopathies , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1153] M. Laredo,et al. Catheter Ablation of Electrical Storm in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. , 2019, Heart rhythm.

[1154] S. Ommen,et al. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort , 2019, The Journal of thoracic and cardiovascular surgery.

[1155] S. Ware,et al. Genetic Testing and Cascade Screening in Pediatric Long QT Syndrome and Hypertrophic Cardiomyopathy. , 2019, Heart rhythm.

[1156] J. Veselka,et al. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy : results from the Euro-ASA registry , 2019 .

[1157] C. Rooryck,et al. Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study , 2018, European heart journal cardiovascular Imaging.

[1158] P. Kellman,et al. CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy. , 2018, JACC. Cardiovascular imaging.

[1159] M. Emdin,et al. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. , 2018, International journal of cardiology.

[1160] T. Edvardsen,et al. Vigorous exercise in patients with hypertrophic cardiomyopathy. , 2018, International journal of cardiology.

[1161] E. Oikonomou,et al. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis. , 2018, Annals of cardiothoracic surgery.

[1162] D. Stacey,et al. Incorporating patients’ preference diagnosis in implantable cardioverter defibrillator decision-making: a review of recent literature , 2018, Current opinion in cardiology.

[1163] Jay A. Montgomery,et al. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. , 2018, Heart rhythm.

[1164] P. Elliott,et al. The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results. , 2018, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[1165] M. Laredo,et al. Total pericardium agenesis mistaken for arrhythmogenic right ventricular cardiomyopathy. , 2018, European heart journal cardiovascular Imaging.

[1166] C. Rapezzi,et al. Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study , 2018, Circulation. Heart failure.

[1167] H. Bundgaard,et al. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. , 2018, The Canadian journal of cardiology.

[1168] V. Fuster,et al. Nuclear cardiology in the literature: A selection of recent, original research papers , 2018, Journal of Nuclear Cardiology.

[1169] James A. White,et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.

[1170] D. Theuns,et al. Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.

[1171] W. Chung,et al. Pediatric Cardiomyopathies. , 2017, Circulation research.

[1172] H. Calkins,et al. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. , 2016, Heart rhythm.

[1173] R. Hauer,et al. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2016, Heart rhythm.

[1174] B. Gersh,et al. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1175] M. Hannan,et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[1176] T. Edvardsen,et al. Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. , 2015, JACC. Cardiovascular imaging.

[1177] B. Maron,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[1178] N. Smedira,et al. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. , 2014, JACC. Cardiovascular imaging.

[1179] S. Wann,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2013, European heart journal cardiovascular Imaging.

[1180] W. Shimizu,et al. Safety and Efficacy of Implantable CardioverterDefibrillator During Pregnancy and After Delivery , 2013 .

[1181] M. Maron,et al. Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .

[1182] R. Brugada,et al. Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation. , 2011, Heart rhythm.

[1183] W. Williams,et al. Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. , 2011, Congenital heart disease.

[1184] T. Ohtsuki,et al. Two cases of cerebral embolism caused by apical thrombi in midventricular obstructive cardiomyopathy. , 2011, Internal medicine.

[1185] W. Toff,et al. Fitness to fly for passengers with cardiovascular disease. , 2010, Heart.

[1186] N. Smedira,et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. , 2008, The Annals of thoracic surgery.